美国6月里奇蒙德联储服务业收入指数 -1，前值14。

At the morning close, Chinese futures main contracts were mostly lower. Shanghai silver fell nearly 5%; coke dropped more than 4%; liquefied petroleum gas (LPG) and Shanghai tin slipped over 3%; low-sulfur fuel oil (LU), platinum, fuel oil and asphalt fell about 3%. On the upside, 20# rubber rose more than 1% and soybean No.1 gained nearly 1%.

Sinovac Biotech’s fully human anti-tetanus monoclonal antibody SNA02-48 injection has entered a Phase III trial, with the first volunteer enrolled at Shenzhen Second People’s Hospital. SNA02-48 was cleared for clinical use in March 2025 and is a recombinant fully human mAb for emergency post-exposure prophylaxis against tetanus. Sinovac is expanding a wound-care portfolio covering active and passive immunity: its adsorbed tetanus vaccine is market-approved; Sinovac-backed Xingmeng Biotech’s Class 1 innovative drug Krebi® (monoclonal antibody injection) is approved for passive immunization of adults exposed to rabies; Sinovac’s lyophilized human rabies vaccine (serum-free Vero cell) is in the regulatory filing stage.